Bal Pharma Limited (BALPHARMA.NS)
INR 105.7
(1.63%)
INR 105.7
(1.63%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 770.19 Million INR | -41.41% |
| 2022 | 1.31 Billion INR | 17.91% |
| 2021 | 1.11 Billion INR | 12.26% |
| 2020 | 993.03 Million INR | 16.16% |
| 2019 | 854.89 Million INR | -18.34% |
| 2018 | 1.04 Billion INR | -2.26% |
| 2017 | 1.07 Billion INR | -4.22% |
| 2016 | 1.11 Billion INR | 23.79% |
| 2015 | 903.45 Million INR | 2.72% |
| 2014 | 879.53 Million INR | 5.16% |
| 2013 | 836.4 Million INR | 21.27% |
| 2012 | 689.69 Million INR | 9.68% |
| 2011 | 628.85 Million INR | 19.18% |
| 2010 | 527.63 Million INR | 14.15% |
| 2009 | 462.25 Million INR | -8.05% |
| 2008 | 502.71 Million INR | 17.28% |
| 2007 | 428.65 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 179.45 Million INR | -22.21% |
| 2023 Q3 | 358.16 Million INR | -8.7% |
| 2023 Q4 | 230.68 Million INR | -35.59% |
| 2023 FY | 770.19 Million INR | -41.41% |
| 2023 Q1 | 313.75 Million INR | -16.0% |
| 2023 Q2 | 392.28 Million INR | 25.03% |
| 2022 Q4 | 373.51 Million INR | 17.69% |
| 2022 Q3 | 317.37 Million INR | -4.91% |
| 2022 Q2 | 333.75 Million INR | 15.16% |
| 2022 Q1 | 289.81 Million INR | 10.52% |
| 2022 FY | 1.31 Billion INR | 17.91% |
| 2021 FY | 1.11 Billion INR | 12.26% |
| 2021 Q1 | 249.46 Million INR | -9.28% |
| 2021 Q3 | 290.64 Million INR | -7.21% |
| 2021 Q2 | 313.22 Million INR | 25.56% |
| 2021 Q4 | 262.22 Million INR | -9.78% |
| 2020 Q1 | 225.06 Million INR | 30.2% |
| 2020 Q2 | 232.51 Million INR | 3.31% |
| 2020 Q3 | 260.46 Million INR | 12.02% |
| 2020 Q4 | 274.98 Million INR | 5.57% |
| 2020 FY | 993.03 Million INR | 16.16% |
| 2019 Q2 | 240.42 Million INR | 2.11% |
| 2019 Q4 | 172.85 Million INR | -16.16% |
| 2019 Q1 | 235.44 Million INR | -11.92% |
| 2019 Q3 | 206.16 Million INR | -14.25% |
| 2019 FY | 854.89 Million INR | -18.34% |
| 2018 Q4 | 267.3 Million INR | 13.13% |
| 2018 FY | 1.04 Billion INR | -2.26% |
| 2018 Q3 | 236.28 Million INR | -21.59% |
| 2018 Q2 | 301.36 Million INR | 27.54% |
| 2018 Q1 | 236.28 Million INR | -25.87% |
| 2017 Q3 | 269.43 Million INR | 0.0% |
| 2017 Q4 | 318.75 Million INR | 18.3% |
| 2017 FY | 1.07 Billion INR | -4.22% |
| 2016 FY | 1.11 Billion INR | 23.79% |
| 2016 Q2 | 311.95 Million INR | 32.38% |
| 2016 Q1 | 235.65 Million INR | -2.02% |
| 2016 Q4 | 335.16 Million INR | 14.15% |
| 2016 Q3 | 293.61 Million INR | -5.88% |
| 2015 Q4 | 240.5 Million INR | -2.53% |
| 2015 Q1 | 203.36 Million INR | -16.74% |
| 2015 FY | 903.45 Million INR | 2.72% |
| 2015 Q2 | 244.74 Million INR | 20.35% |
| 2015 Q3 | 246.74 Million INR | 0.82% |
| 2014 Q3 | 204.75 Million INR | -8.98% |
| 2014 FY | 879.53 Million INR | 5.16% |
| 2014 Q4 | 244.24 Million INR | 19.28% |
| 2014 Q2 | 224.95 Million INR | 9.43% |
| 2014 Q1 | 205.57 Million INR | -7.44% |
| 2013 Q4 | 222.09 Million INR | 7.09% |
| 2013 FY | 836.4 Million INR | 21.27% |
| 2013 Q2 | 209.33 Million INR | 5.95% |
| 2013 Q1 | 197.58 Million INR | 1.8% |
| 2013 Q3 | 207.39 Million INR | -0.93% |
| 2012 Q2 | 168.39 Million INR | 9.3% |
| 2012 Q4 | 194.09 Million INR | 12.11% |
| 2012 FY | 689.69 Million INR | 9.68% |
| 2012 Q1 | 154.07 Million INR | -18.3% |
| 2012 Q3 | 173.13 Million INR | 2.81% |
| 2011 FY | 628.85 Million INR | 19.18% |
| 2011 Q4 | 188.57 Million INR | 23.94% |
| 2011 Q3 | 152.15 Million INR | -2.43% |
| 2011 Q2 | 155.94 Million INR | 0.0% |
| 2010 FY | 527.63 Million INR | 14.15% |
| 2009 FY | 462.25 Million INR | -8.05% |
| 2008 FY | 502.71 Million INR | 17.28% |
| 2007 FY | 428.65 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 97.124% |
| Hester Biosciences Limited | 1.27 Billion INR | 39.529% |
| Aarti Drugs Limited | 8.31 Billion INR | 90.739% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 86.792% |
| Albert David Limited | 1.4 Billion INR | 45.302% |
| Alembic Limited | 1 Billion INR | 22.989% |
| Alkem Laboratories Limited | 52.29 Billion INR | 98.527% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -70.339% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 47.67% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -6039.458% |
| Brooks Laboratories Limited | 65.62 Million INR | -1073.72% |
| Eris Lifesciences Limited | 10.42 Billion INR | 92.613% |
| FDC Limited | 6.58 Billion INR | 88.306% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 93.805% |
| Gufic Biosciences Limited | 4.07 Billion INR | 81.094% |
| Hikal Limited | 5.95 Billion INR | 87.073% |
| Ind-Swift Limited | 2.17 Billion INR | 64.548% |
| Innova Captab Limited | 3.46 Billion INR | 77.769% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 83.679% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -18.021% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 96.079% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 59.181% |
| Lupin Limited | 125.09 Billion INR | 99.384% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -11.43% |
| Medico Remedies Limited | 262.14 Million INR | -193.806% |
| Morepen Laboratories Limited | 6.16 Billion INR | 87.499% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 84.032% |
| Orchid Pharma Limited | 2.32 Billion INR | 66.806% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 86.678% |
| RPG Life Sciences Limited | 2.48 Billion INR | 68.981% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -24.13% |
| Sigachi Industries Limited | 2 Billion INR | 61.534% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 146.512% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 81.321% |
| Themis Medicare Limited | 2.42 Billion INR | 68.174% |
| Unichem Laboratories Limited | 4.86 Billion INR | 84.168% |
| Vaishali Pharma Limited | 90.32 Million INR | -752.712% |
| Wanbury Limited | 1.73 Billion INR | 55.497% |
| Windlas Biotech Limited | 1.33 Billion INR | 42.471% |
| ZIM Laboratories Limited | 1.26 Billion INR | 39.25% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 81.366% |
| Ipca Laboratories Limited | 48.58 Billion INR | 98.415% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.702% |
| Venus Remedies Limited | 2.18 Billion INR | 64.712% |
| Sakar Healthcare Limited | 699.58 Million INR | -10.093% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 99.297% |
| Divi's Laboratories Limited | 32.44 Billion INR | 97.626% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 87.623% |
| Mankind Pharma Limited | 42.19 Billion INR | 98.175% |
| Sequent Scientific Limited | 2.97 Billion INR | 74.144% |
| Laurus Labs Limited | 15.44 Billion INR | 95.014% |
| Neuland Laboratories Limited | 8.24 Billion INR | 90.662% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 94.952% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 98.889% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 99.385% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 63.22% |
| Wockhardt Limited | 7.72 Billion INR | 90.023% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.529% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 79.158% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -45.557% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 91.634% |
| Shilpa Medicare Limited | 3.56 Billion INR | 78.377% |
| Valiant Laboratories Limited | 138.02 Million INR | -457.995% |
| Ajanta Pharma Limited | 21.06 Billion INR | 96.344% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -581.414% |
| Granules India Limited | 16.79 Billion INR | 95.415% |
| Medicamen Biotech Limited | 495.49 Million INR | -55.44% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -37.657% |
| Piramal Enterprises Limited | 8.04 Billion INR | 90.424% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 98.353% |
| NATCO Pharma Limited | 25.73 Billion INR | 97.007% |
| Suven Life Sciences Limited | -200.79 Million INR | 483.569% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 808.245% |
| Strides Pharma Science Limited | 14.38 Billion INR | 94.647% |
| Indoco Remedies Limited | 8.04 Billion INR | 90.424% |
| Alpa Laboratories Limited | 188.89 Million INR | -307.737% |
| Lasa Supergenerics Limited | 121.02 Million INR | -536.367% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -96.948% |